Anti-inflammatory activity of ivermectin in late-stage COVID-19 may reflect activation of systemic glycine receptors
Dr James J Dinicolantonio, Jorge Barroso-Aranda, Mark F Mccarty
Open Heart, doi:10.1136/openhrt-2021-001655
somewhat analogous anti-inflammatory protection in COVID-19, as has previously been suggested. 26 27 However, in light of accumulating evidence that ivermectin may have important utility for the primary prevention of COVID-19, it is likely that it also exerts an antiviral effect with respect to SARS-CoV-2, as suggested by in vitro studies. 3 28 It is not clear whether glycine receptor agonism might have anything to do with this effect.
References
Baudou, Lespine, Durrieu, Serious Ivermectin Toxicity and Human ABCB1 Nonsense Mutations, N Engl J Med,
doi:10.1056/NEJMc1917344Didier, Loor, Decreased biotolerability for ivermectin and cyclosporin A in mice exposed to potent P-glycoprotein inhibitors, Int J Cancer,
doi:10.1002/ijc.2910630220Ding, Svingen, Pedersen, Plasma glycine and risk of acute myocardial infarction in patients with suspected stable angina pectoris, J Am Heart Assoc,
doi:10.1161/JAHA.115.002621Dinicolantonio, Barroso, Mccarty, Ivermectin may be a clinically useful anti-inflammatory agent for late-stage COVID-19, Open Heart,
doi:10.1136/openhrt-2020-001350Dinicolantonio, Mccarty, Thrombotic complications of COVID-19 may reflect an upregulation of endothelial tissue factor expression that is contingent on activation of endosomal NADPH oxidase, Open Heart,
doi:10.1136/openhrt-2020-001337Froh, Thurman, Wheeler, Molecular evidence for a glycine-gated chloride channel in macrophages and leukocytes, Am J Physiol Gastrointest Liver Physiol,
doi:10.1152/ajpgi.00503.2001Li, Bradford, Wheeler, Dietary glycine prevents peptidoglycan polysaccharide-induced reactive arthritis in the rat: role for glycine-gated chloride channel, Infect Immun,
doi:10.1128/IAI.69.9.5883-5891.2001Lynagh, Webb, Dixon, Molecular determinants of ivermectin sensitivity at the glycine receptor chloride channel, J Biol Chem,
doi:10.1074/jbc.M111.262634Mccarty, Iloki-Assanga, Lujan, Activated glycine receptors may decrease endosomal NADPH oxidase activity by opposing ClC-3-mediated efflux of chloride from endosomes, Med Hypotheses,
doi:10.1016/j.mehy.2019.01.012Rodrigues, De Sá, Ishimoto, Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients, J Exp Med,
doi:10.1084/jem.20201707Schmith, Zhou, Lohmer, The Approved dose of ivermectin alone is not the ideal dose for the treatment of COVID-19, Clin Pharmacol Ther,
doi:10.1002/cpt.1889Shan, Haddrill, Lynch, Ivermectin, Ivermectin, an unconventional agonist of the glycine receptor chloride channel, J Biol Chem,
doi:10.1074/jbc.M011264200Viktorov, Ivermectin inhibits activation of Kupffer cells induced by lipopolysaccharide toxin
Wang, Lynch, A comparison of glycine-and ivermectinmediated conformational changes in the glycine receptor ligandbinding domain, Int J Biochem Cell Biol,
doi:10.1016/j.biocel.2011.11.005Wheeler, Rose, Yamashima, Dietary glycine blunts lung inflammatory cell influx following acute endotoxin, Am J Physiol Lung Cell Mol Physiol,
doi:10.1152/ajplung.2000.279.2.L390Wheeler, Stachlewitz, Yamashina, Glycine-gated chloride channels in neutrophils attenuate calcium influx and superoxide production, Faseb J,
doi:10.1096/fasebj.14.3.476Zhang, Ma, Jiang, Glycine attenuates lipopolysaccharideinduced acute lung injury by regulating NLRP3 inflammasome and NRF2 signaling, Nutrients,
doi:10.3390/nu12030611Zhang, Song, Ci, Ivermectin inhibits LPS-induced production of inflammatory cytokines and improves LPS-induced survival in mice, Inflamm Res,
doi:10.1007/s00011-008-8007-8DOI record:
{
"DOI": "10.1136/openhrt-2021-001655",
"ISSN": [
"2053-3624"
],
"URL": "http://dx.doi.org/10.1136/openhrt-2021-001655",
"alternative-id": [
"10.1136/openhrt-2021-001655"
],
"author": [
{
"ORCID": "http://orcid.org/0000-0002-7888-1528",
"affiliation": [],
"authenticated-orcid": false,
"family": "DiNicolantonio",
"given": "James J",
"sequence": "first"
},
{
"affiliation": [],
"family": "Barroso-Aranda",
"given": "Jorge",
"sequence": "additional"
},
{
"affiliation": [],
"family": "McCarty",
"given": "Mark F",
"sequence": "additional"
}
],
"container-title": "Open Heart",
"container-title-short": "Open Heart",
"content-domain": {
"crossmark-restriction": true,
"domain": [
"bmj.com"
]
},
"created": {
"date-parts": [
[
2021,
4,
19
]
],
"date-time": "2021-04-19T16:39:13Z",
"timestamp": 1618850353000
},
"deposited": {
"date-parts": [
[
2021,
4,
19
]
],
"date-time": "2021-04-19T16:39:54Z",
"timestamp": 1618850394000
},
"indexed": {
"date-parts": [
[
2023,
4,
11
]
],
"date-time": "2023-04-11T08:08:39Z",
"timestamp": 1681200519757
},
"is-referenced-by-count": 6,
"issue": "1",
"issued": {
"date-parts": [
[
2021,
4
]
]
},
"journal-issue": {
"issue": "1",
"published-online": {
"date-parts": [
[
2021,
4,
19
]
]
},
"published-print": {
"date-parts": [
[
2021,
4
]
]
}
},
"language": "en",
"license": [
{
"URL": "http://creativecommons.org/licenses/by-nc/4.0/",
"content-version": "unspecified",
"delay-in-days": 18,
"start": {
"date-parts": [
[
2021,
4,
19
]
],
"date-time": "2021-04-19T00:00:00Z",
"timestamp": 1618790400000
}
}
],
"link": [
{
"URL": "https://syndication.highwire.org/content/doi/10.1136/openhrt-2021-001655",
"content-type": "unspecified",
"content-version": "vor",
"intended-application": "similarity-checking"
}
],
"member": "239",
"original-title": [],
"page": "e001655",
"prefix": "10.1136",
"published": {
"date-parts": [
[
2021,
4
]
]
},
"published-online": {
"date-parts": [
[
2021,
4,
19
]
]
},
"published-print": {
"date-parts": [
[
2021,
4
]
]
},
"publisher": "BMJ",
"reference": [
{
"DOI": "10.1007/s00011-008-8007-8",
"doi-asserted-by": "publisher",
"key": "2021041909351020000_8.1.e001655.1"
},
{
"DOI": "10.1136/openhrt-2020-001350",
"doi-asserted-by": "publisher",
"key": "2021041909351020000_8.1.e001655.2"
},
{
"key": "2021041909351020000_8.1.e001655.3",
"unstructured": "Covid Analysis . Ivermectin is effective for COVID-19: real-time meta analysis of 44 studies, 2021."
},
{
"DOI": "10.1074/jbc.M011264200",
"doi-asserted-by": "publisher",
"key": "2021041909351020000_8.1.e001655.4"
},
{
"DOI": "10.1074/jbc.M111.262634",
"doi-asserted-by": "publisher",
"key": "2021041909351020000_8.1.e001655.5"
},
{
"DOI": "10.1016/j.biocel.2011.11.005",
"article-title": "A comparison of glycine- and ivermectin-mediated conformational changes in the glycine receptor ligand-binding domain",
"author": "Wang",
"doi-asserted-by": "crossref",
"first-page": "335",
"journal-title": "Int J Biochem Cell Biol",
"key": "2021041909351020000_8.1.e001655.6",
"volume": "44",
"year": "2012"
},
{
"DOI": "10.1007/s000180050030",
"doi-asserted-by": "publisher",
"key": "2021041909351020000_8.1.e001655.7"
},
{
"article-title": "Kupffer cells contain a glycine-gated chloride channel",
"author": "Ikejima",
"first-page": "G1581",
"journal-title": "Am J Physiol",
"key": "2021041909351020000_8.1.e001655.8",
"volume": "272",
"year": "1997"
},
{
"DOI": "10.1128/IAI.69.9.5883-5891.2001",
"doi-asserted-by": "publisher",
"key": "2021041909351020000_8.1.e001655.9"
},
{
"DOI": "10.1152/ajpgi.00503.2001",
"doi-asserted-by": "publisher",
"key": "2021041909351020000_8.1.e001655.10"
},
{
"DOI": "10.1152/ajplung.2000.279.2.L390",
"article-title": "Dietary glycine blunts lung inflammatory cell influx following acute endotoxin",
"author": "Wheeler",
"doi-asserted-by": "crossref",
"first-page": "L390",
"journal-title": "Am J Physiol Lung Cell Mol Physiol",
"key": "2021041909351020000_8.1.e001655.11",
"volume": "279",
"year": "2000"
},
{
"DOI": "10.1096/fasebj.14.3.476",
"article-title": "Glycine-gated chloride channels in neutrophils attenuate calcium influx and superoxide production",
"author": "Wheeler",
"doi-asserted-by": "crossref",
"first-page": "476",
"journal-title": "Faseb J",
"key": "2021041909351020000_8.1.e001655.12",
"volume": "14",
"year": "2000"
},
{
"article-title": "Production of superoxide and TNF-alpha from alveolar macrophages is blunted by glycine",
"author": "Wheeler",
"first-page": "L952",
"journal-title": "Am J Physiol",
"key": "2021041909351020000_8.1.e001655.13",
"volume": "277",
"year": "1999"
},
{
"DOI": "10.1207/S15327914NC402_17",
"doi-asserted-by": "publisher",
"key": "2021041909351020000_8.1.e001655.14"
},
{
"DOI": "10.1016/j.mehy.2019.01.012",
"article-title": "Activated glycine receptors may decrease endosomal NADPH oxidase activity by opposing ClC-3-mediated efflux of chloride from endosomes",
"author": "McCarty",
"doi-asserted-by": "crossref",
"first-page": "125",
"journal-title": "Med Hypotheses",
"key": "2021041909351020000_8.1.e001655.15",
"volume": "123",
"year": "2019"
},
{
"article-title": "A diet containing glycine improves survival in endotoxin shock in the rat",
"author": "Ikejima",
"first-page": "G97",
"journal-title": "Am J Physiol",
"key": "2021041909351020000_8.1.e001655.16",
"volume": "271",
"year": "1996"
},
{
"DOI": "10.1084/jem.20201707",
"article-title": "Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients",
"author": "Rodrigues",
"doi-asserted-by": "crossref",
"journal-title": "J Exp Med",
"key": "2021041909351020000_8.1.e001655.17",
"volume": "218",
"year": "2021"
},
{
"article-title": "Glycine attenuates lipopolysaccharide-induced acute lung injury by regulating NLRP3 inflammasome and NRF2 signaling",
"author": "Zhang",
"journal-title": "Nutrients",
"key": "2021041909351020000_8.1.e001655.18",
"volume": "12",
"year": "2020"
},
{
"article-title": "[Ivermectin inhibits activation of Kupffer cells induced by lipopolysaccharide toxin]",
"author": "Viktorov",
"first-page": "3",
"journal-title": "Antibiot Khimioter",
"key": "2021041909351020000_8.1.e001655.19",
"volume": "48",
"year": "2003"
},
{
"DOI": "10.1002/cpt.1889",
"article-title": "The Approved dose of ivermectin alone is not the ideal dose for the treatment of COVID-19",
"author": "Schmith",
"doi-asserted-by": "crossref",
"first-page": "762",
"journal-title": "Clin Pharmacol Ther",
"key": "2021041909351020000_8.1.e001655.20",
"volume": "108",
"year": "2020"
},
{
"DOI": "10.1152/physrev.00042.2003",
"doi-asserted-by": "publisher",
"key": "2021041909351020000_8.1.e001655.21"
},
{
"article-title": "Plasma glycine and risk of acute myocardial infarction in patients with suspected stable angina pectoris",
"author": "Ding",
"journal-title": "J Am Heart Assoc",
"key": "2021041909351020000_8.1.e001655.22",
"volume": "5",
"year": "2015"
},
{
"DOI": "10.1002/ijc.2910630220",
"article-title": "Decreased biotolerability for ivermectin and cyclosporin A in mice exposed to potent P-glycoprotein inhibitors",
"author": "Didier",
"doi-asserted-by": "crossref",
"first-page": "263",
"journal-title": "Int J Cancer",
"key": "2021041909351020000_8.1.e001655.23",
"volume": "63",
"year": "1995"
},
{
"DOI": "10.1097/00008571-200111000-00012",
"doi-asserted-by": "publisher",
"key": "2021041909351020000_8.1.e001655.24"
},
{
"DOI": "10.1056/NEJMc1917344",
"article-title": "Serious Ivermectin Toxicity and Human ABCB1 Nonsense Mutations",
"author": "Baudou",
"doi-asserted-by": "crossref",
"first-page": "787",
"journal-title": "N Engl J Med",
"key": "2021041909351020000_8.1.e001655.25",
"volume": "383",
"year": "2020"
},
{
"DOI": "10.1136/openhrt-2020-001337",
"doi-asserted-by": "publisher",
"key": "2021041909351020000_8.1.e001655.26"
},
{
"DOI": "10.1667/RADE-20-00146.1",
"article-title": "Can glycine mitigate COVID-19 associated tissue damage and cytokine storm?",
"author": "Li",
"doi-asserted-by": "crossref",
"first-page": "199",
"journal-title": "Radiat Res",
"key": "2021041909351020000_8.1.e001655.27",
"volume": "194",
"year": "2020"
},
{
"DOI": "10.1016/j.antiviral.2020.104787",
"article-title": "The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro",
"author": "Caly",
"doi-asserted-by": "crossref",
"journal-title": "Antiviral Res",
"key": "2021041909351020000_8.1.e001655.28",
"volume": "178",
"year": "2020"
}
],
"reference-count": 28,
"references-count": 28,
"relation": {},
"resource": {
"primary": {
"URL": "https://openheart.bmj.com/lookup/doi/10.1136/openhrt-2021-001655"
}
},
"score": 1,
"short-title": [],
"source": "Crossref",
"subject": [
"Cardiology and Cardiovascular Medicine"
],
"subtitle": [],
"title": "Anti-inflammatory activity of ivermectin in late-stage COVID-19 may reflect activation of systemic glycine receptors",
"type": "journal-article",
"update-policy": "http://dx.doi.org/10.1136/crossmarkpolicy",
"volume": "8"
}
